Mark T. Iwicki, CHIEF EXECUTIVE OFFICER at KALA BIO, Inc. (KALA), sold 4,539 shares at $6.73 ($31K) on 2024-01-04, disclosed to the SEC on 2024-01-05.
Scheduled sale ($31k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KALA | SELL | 2025-06-05 | $41K | — | Filing → |
| KALA | SELL | 2025-01-07 | $44K | — | Filing → |
| KALA | SELL | 2024-06-27 | $72K | — | Filing → |